Voting is now open for the SFPM Elections! This is your chance to help shape the future of our organization by selecting the leaders who will represent and guide our mission. If you are a Member, cast your vote today!
Vote now: https://t.co/GsEfSpeadv
Congratulations @DrTonyLetai ! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing!
@DrTonyLetai In light of this transition, new Board openings will be announced, with elections to follow. SfPM members will receive additional details in the coming weeks.
Stay tuned: https://t.co/rCliw11Jmm
The Society for Functional Precision Medicine (SfPM) congratulates our President, @DrTonyLetai, on his appointment as Director of the National Cancer Institute (NCI) /thread
https://t.co/DmJFuMhZG6
@DrTonyLetai We are inspired to see Dr. Letai bring his stabilizing, trailblazing force to the NCI at such a critical time for cancer research. Please join us in thanking him for his service to SfPM and congratulating him on this momentous new chapter.
🚨 New Article Alert! Dive into a fantastic review by several @TheSFPM members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!
https://t.co/CcPsCQZbYR
Join us *today* Wednesday 03/12 @ 12:00 PM EST for our monthly SFPM seminar! Dr. Perova from @emblebi will discuss: "Leveraging https://t.co/V7lwNqdBaB: enhancing precision oncology through collaborative cancer model resources"
https://t.co/ohnuFm6QxS
Join us *today* Wednesday 02/12 @ 12:00 PM EST for our monthly SFPM seminar!
Dr. Andrew Satterlee from @UNC will discuss overcoming systemic barriers to functional precision medicine using a versatile ex vivo model of patient brain tumors
An exciting multicenter phase 2 functional precision medicine clinical trial showing how a rapid ex vivo venetoclax sensitivity assay was the strongest predictor for a favorable treatment response and survival in relapsed/refractory secondary AML
https://t.co/ccEG0vbCdU
Join us *tomorrow* Wednesday 12/11 @ 12:00 PM EST for our last monthly SFPM seminar of the year!
Drs. Damle and Pillarisetty from @fredhutch will discuss tumor slice cultures as a window into the human TME.
Info to join here: https://t.co/kgSH1bO1Hu
Joan Montero describing his huge contributions to the cell death field and the discovery of dynamic BH3 profiling that has huge potential for precision medicine @JoanMonte@TheSFPM
Submit an abstract by November 15 for the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer (March 11-13, Boston), chaired by Anthony Letai, Elaine Mardis, Peter Horak, and Alice Soragni.
https://t.co/vA0IuZHk9i
#AACRprecmed25@DrTonyLetai@soragnilab
🚨NEW study from our LAB showing the predictive value of Patient-derived Breast Cancer 🐟zebrafish Avatars ! A co-clinical study where we compare the patient clinical response to treatment with their matching 🐟zAvatar! ✨100% @ChampalimaudF@TheSFPM
https://t.co/XTlfR8GE1W
Submit an abstract by November 15 for the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer (March 11-13, Boston), chaired by Anthony Letai, Elaine Mardis, Peter Horak, and Alice Soragni.
https://t.co/yQwl4kkfIa
#AACRprecmed25@DrTonyLetai@soragnilab
What an inspiring week at the EHA-SFPM Congress in Copenhagen! Thank you to all the researchers, clinicians, and innovators who continue to push the limits of what’s possible. The future of science is collaborative & I’m excited for what’s coming . #PrecisionMedicine#EHASFPM